Patents by Inventor Alenka Kosak

Alenka Kosak has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Crystalline form of omeprazole
    Patent number: 7553856
    Abstract: A novel crystalline form of the substrate known under the chemical name 5-methoxy-2-[[(4-methoxy-3,5-dimethyl-2-pyridinyl)methyl]sulfiny]-1H-benzimidazole, and having the generic name omeprazole, hereinafter referred to as omeprozole form C, is disclosed. Further, a process for the preparation of omeprazole form C, a pharmaceutical formulation containing omeprazole form C in admixture with pharmaceutically acceptable excipients and the use of omeprazole form C for treatment of gastrointestinal disorders are disclosed.
    Type: Grant
    Filed: October 12, 2005
    Date of Patent: June 30, 2009
    Assignee: Lek Pharmaceuticals d.d.
    Inventors: Natasa H Milac, Anton Copar, Barbara Podobnik, Andreja C Belcic, Alenka Kosak, Brina Ornik, Uros Urleb
  • Crystalline form of omeprazole
    Publication number: 20060079560
    Abstract: A novel crystalline form of the substrate known under the chemical name 5-methoxy-2-[[(4-methoxy-3,5-dimethyl-2-pyridinyl)methyl]sulfiny]-1H-benzimidazole, and having the generic name omeprazole, hereinafter referred to as omeprozole form C, is disclosed. Further, a process for the preparation of omeprazole form C, a pharmaceutical formulation containing omeprazole form C in admixture with pharmaceutically acceptable excipients and the use of omeprazole form C for treatment of gastrointestinal disorders are disclosed.
    Type: Application
    Filed: October 12, 2005
    Publication date: April 13, 2006
    Inventors: Natasa Milac, Anton Copar, Barbara Podobnik, Andreja Belcic, Alenka Kosak, Brina Ornik, Uros Urleb
  • Crystalline form of omeprazole
    Publication number: 20040122056
    Abstract: A novel crystalline form of the substrate known under the chemical name 5-methoxy-2-[[(4-methoxy-3,5-dimethyl-2-pyridinyl)methyl]sulfiny] -1H-benzimidazole, and having the generic name omeprazole, hereinafter referred to as omeprozole form C, is disclosed. Further, a process for the preparation of omeprazole form C, a pharmaceutical formulation containing omeprazole form C in admixture with pharmaceutically acceptable excipients and the use of omeprazole form C for treatment of gastrointestinal disorders are disclosed.
    Type: Application
    Filed: October 17, 2003
    Publication date: June 24, 2004
    Inventors: Natasa Hafner Milac, Anton Copar, Barbara Podobnik, Andreja Cizerle Belcic, Alenka Kosak, Brina Ornik, Uros Urleb